nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC3—hematologic cancer	0.156	0.526	CbGaD
Glyburide—ABCG2—hematologic cancer	0.0757	0.256	CbGaD
Glyburide—ALB—hematologic cancer	0.033	0.112	CbGaD
Glyburide—ABCB1—hematologic cancer	0.0315	0.106	CbGaD
Glyburide—ABCC1—Idarubicin—hematologic cancer	0.0181	0.0404	CbGbCtD
Glyburide—ABCB11—Daunorubicin—hematologic cancer	0.018	0.0402	CbGbCtD
Glyburide—SLCO1A2—Chlorambucil—hematologic cancer	0.0161	0.0361	CbGbCtD
Glyburide—ABCG2—Clofarabine—hematologic cancer	0.0146	0.0326	CbGbCtD
Glyburide—ABCC1—Daunorubicin—hematologic cancer	0.0128	0.0286	CbGbCtD
Glyburide—ABCC2—Daunorubicin—hematologic cancer	0.00946	0.0212	CbGbCtD
Glyburide—ABCC3—Vincristine—hematologic cancer	0.0087	0.0195	CbGbCtD
Glyburide—ABCG2—Daunorubicin—hematologic cancer	0.00855	0.0191	CbGbCtD
Glyburide—ABCC3—Cisplatin—hematologic cancer	0.00812	0.0182	CbGbCtD
Glyburide—ABCC3—Etoposide—hematologic cancer	0.00798	0.0178	CbGbCtD
Glyburide—ABCC1—Mitoxantrone—hematologic cancer	0.00777	0.0174	CbGbCtD
Glyburide—ABCB11—Vinblastine—hematologic cancer	0.00765	0.0171	CbGbCtD
Glyburide—ABCB11—Vincristine—hematologic cancer	0.00752	0.0168	CbGbCtD
Glyburide—ABCG2—Teniposide—hematologic cancer	0.00743	0.0166	CbGbCtD
Glyburide—ABCG2—Cladribine—hematologic cancer	0.00712	0.0159	CbGbCtD
Glyburide—ABCG2—Imatinib—hematologic cancer	0.00655	0.0146	CbGbCtD
Glyburide—ABCC1—Epirubicin—hematologic cancer	0.00629	0.0141	CbGbCtD
Glyburide—ABCC1—Irinotecan—hematologic cancer	0.00611	0.0137	CbGbCtD
Glyburide—SLCO1A2—Prednisolone—hematologic cancer	0.0061	0.0136	CbGbCtD
Glyburide—ABCG2—Nilotinib—hematologic cancer	0.00595	0.0133	CbGbCtD
Glyburide—SLCO1A2—Prednisone—hematologic cancer	0.00576	0.0129	CbGbCtD
Glyburide—ABCB11—Dexamethasone—hematologic cancer	0.00567	0.0127	CbGbCtD
Glyburide—ABCC3—Doxorubicin—hematologic cancer	0.00544	0.0122	CbGbCtD
Glyburide—ABCC1—Vinblastine—hematologic cancer	0.00544	0.0122	CbGbCtD
Glyburide—CYP2C9—Bexarotene—hematologic cancer	0.00542	0.0121	CbGbCtD
Glyburide—ABCC1—Vincristine—hematologic cancer	0.00534	0.012	CbGbCtD
Glyburide—ABCC3—Methotrexate—hematologic cancer	0.00527	0.0118	CbGbCtD
Glyburide—ABCG2—Dasatinib—hematologic cancer	0.00526	0.0118	CbGbCtD
Glyburide—ABCB1—Lenalidomide—hematologic cancer	0.00526	0.0118	CbGbCtD
Glyburide—ABCG2—Mitoxantrone—hematologic cancer	0.0052	0.0116	CbGbCtD
Glyburide—ABCC1—Etoposide—hematologic cancer	0.0049	0.011	CbGbCtD
Glyburide—ABCB11—Doxorubicin—hematologic cancer	0.0047	0.0105	CbGbCtD
Glyburide—ABCC2—Irinotecan—hematologic cancer	0.00453	0.0101	CbGbCtD
Glyburide—ALB—Imatinib—hematologic cancer	0.00452	0.0101	CbGbCtD
Glyburide—CYP2C9—Idarubicin—hematologic cancer	0.00449	0.01	CbGbCtD
Glyburide—SLC22A7—Methotrexate—hematologic cancer	0.00412	0.00921	CbGbCtD
Glyburide—ABCG2—Irinotecan—hematologic cancer	0.00409	0.00915	CbGbCtD
Glyburide—ABCC2—Vinblastine—hematologic cancer	0.00402	0.009	CbGbCtD
Glyburide—CYP2C19—Bortezomib—hematologic cancer	0.004	0.00893	CbGbCtD
Glyburide—ABCC2—Vincristine—hematologic cancer	0.00396	0.00885	CbGbCtD
Glyburide—ABCC2—Cisplatin—hematologic cancer	0.00369	0.00825	CbGbCtD
Glyburide—ABCC2—Etoposide—hematologic cancer	0.00362	0.00811	CbGbCtD
Glyburide—SLCO1A2—Dexamethasone—hematologic cancer	0.00359	0.00804	CbGbCtD
Glyburide—ABCG2—Vincristine—hematologic cancer	0.00358	0.008	CbGbCtD
Glyburide—CYP2C19—Thalidomide—hematologic cancer	0.00348	0.00778	CbGbCtD
Glyburide—ABCC1—Doxorubicin—hematologic cancer	0.00334	0.00747	CbGbCtD
Glyburide—ABCG2—Cisplatin—hematologic cancer	0.00334	0.00746	CbGbCtD
Glyburide—CYP2C9—Bortezomib—hematologic cancer	0.00332	0.00743	CbGbCtD
Glyburide—CYP2C19—Teniposide—hematologic cancer	0.00332	0.00743	CbGbCtD
Glyburide—ABCG2—Etoposide—hematologic cancer	0.00328	0.00733	CbGbCtD
Glyburide—ABCC1—Methotrexate—hematologic cancer	0.00324	0.00724	CbGbCtD
Glyburide—CYP3A4—Bexarotene—hematologic cancer	0.00315	0.00705	CbGbCtD
Glyburide—ABCB1—Daunorubicin—hematologic cancer	0.00308	0.0069	CbGbCtD
Glyburide—CYP2C19—Ifosfamide—hematologic cancer	0.00306	0.00685	CbGbCtD
Glyburide—ABCB1—Alitretinoin—hematologic cancer	0.00302	0.00676	CbGbCtD
Glyburide—ABCC2—Dexamethasone—hematologic cancer	0.00298	0.00666	CbGbCtD
Glyburide—ALB—Prednisone—hematologic cancer	0.00298	0.00665	CbGbCtD
Glyburide—CYP3A4—Lomustine—hematologic cancer	0.00293	0.00655	CbGbCtD
Glyburide—CYP3A4—Busulfan—hematologic cancer	0.00293	0.00655	CbGbCtD
Glyburide—CYP2C19—Imatinib—hematologic cancer	0.00293	0.00655	CbGbCtD
Glyburide—CYP2C9—Thalidomide—hematologic cancer	0.00289	0.00647	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—hematologic cancer	0.00289	0.00646	CbGbCtD
Glyburide—ALB—Irinotecan—hematologic cancer	0.00282	0.00631	CbGbCtD
Glyburide—CYP2C9—Teniposide—hematologic cancer	0.00276	0.00617	CbGbCtD
Glyburide—KCNJ5—hematopoietic system—hematologic cancer	0.0027	0.0737	CbGeAlD
Glyburide—ABCG2—Dexamethasone—hematologic cancer	0.00269	0.00603	CbGbCtD
Glyburide—CYP3A4—Thiotepa—hematologic cancer	0.00261	0.00584	CbGbCtD
Glyburide—CYP2C9—Ifosfamide—hematologic cancer	0.00255	0.0057	CbGbCtD
Glyburide—ABCC2—Doxorubicin—hematologic cancer	0.00247	0.00553	CbGbCtD
Glyburide—CYP2C9—Imatinib—hematologic cancer	0.00243	0.00544	CbGbCtD
Glyburide—ABCC2—Methotrexate—hematologic cancer	0.00239	0.00536	CbGbCtD
Glyburide—ABCB1—Imatinib—hematologic cancer	0.00236	0.00528	CbGbCtD
Glyburide—ABCG2—Doxorubicin—hematologic cancer	0.00224	0.005	CbGbCtD
Glyburide—CYP2C9—Nilotinib—hematologic cancer	0.00221	0.00495	CbGbCtD
Glyburide—ABCG2—Methotrexate—hematologic cancer	0.00217	0.00484	CbGbCtD
Glyburide—ABCB1—Nilotinib—hematologic cancer	0.00215	0.0048	CbGbCtD
Glyburide—ABCB1—Vinorelbine—hematologic cancer	0.00213	0.00476	CbGbCtD
Glyburide—CYP3A4—Methoxsalen—hematologic cancer	0.00203	0.00454	CbGbCtD
Glyburide—CYP3A4—Bortezomib—hematologic cancer	0.00193	0.00432	CbGbCtD
Glyburide—CYP2C19—Prednisone—hematologic cancer	0.00193	0.00431	CbGbCtD
Glyburide—ABCB1—Dasatinib—hematologic cancer	0.0019	0.00424	CbGbCtD
Glyburide—ABCB1—Mitoxantrone—hematologic cancer	0.00187	0.00419	CbGbCtD
Glyburide—CYP3A4—Daunorubicin—hematologic cancer	0.00185	0.00413	CbGbCtD
Glyburide—SLC22A6—Methotrexate—hematologic cancer	0.00175	0.00392	CbGbCtD
Glyburide—ABCB1—Betamethasone—hematologic cancer	0.00167	0.00373	CbGbCtD
Glyburide—ABCB1—Gemcitabine—hematologic cancer	0.00166	0.0037	CbGbCtD
Glyburide—ABCB1—Prednisolone—hematologic cancer	0.00165	0.00369	CbGbCtD
Glyburide—CYP3A4—Cytarabine—hematologic cancer	0.00163	0.00364	CbGbCtD
Glyburide—CYP3A4—Teniposide—hematologic cancer	0.00161	0.00359	CbGbCtD
Glyburide—KCNJ5—lung—hematologic cancer	0.00157	0.0428	CbGeAlD
Glyburide—ABCB1—Prednisone—hematologic cancer	0.00156	0.00348	CbGbCtD
Glyburide—ALB—Methotrexate—hematologic cancer	0.00149	0.00334	CbGbCtD
Glyburide—CPT1A—hematopoietic system—hematologic cancer	0.00149	0.0407	CbGeAlD
Glyburide—CYP3A4—Ifosfamide—hematologic cancer	0.00148	0.00331	CbGbCtD
Glyburide—ABCB1—Irinotecan—hematologic cancer	0.00148	0.0033	CbGbCtD
Glyburide—CYP3A4—Imatinib—hematologic cancer	0.00142	0.00316	CbGbCtD
Glyburide—ABCA1—hematopoietic system—hematologic cancer	0.00139	0.0379	CbGeAlD
Glyburide—CYP3A4—Ruxolitinib—hematologic cancer	0.00133	0.00298	CbGbCtD
Glyburide—CFTR—hematopoietic system—hematologic cancer	0.00131	0.0358	CbGeAlD
Glyburide—ABCB1—Vinblastine—hematologic cancer	0.00131	0.00293	CbGbCtD
Glyburide—ABCB1—Vincristine—hematologic cancer	0.00129	0.00288	CbGbCtD
Glyburide—CYP3A4—Nilotinib—hematologic cancer	0.00129	0.00288	CbGbCtD
Glyburide—CYP3A4—Vinorelbine—hematologic cancer	0.00128	0.00285	CbGbCtD
Glyburide—CYP2C9—Cisplatin—hematologic cancer	0.00124	0.00277	CbGbCtD
Glyburide—CYP2C19—Dexamethasone—hematologic cancer	0.0012	0.00269	CbGbCtD
Glyburide—ABCB1—Cisplatin—hematologic cancer	0.0012	0.00269	CbGbCtD
Glyburide—ABCC9—lung—hematologic cancer	0.00119	0.0325	CbGeAlD
Glyburide—ABCB1—Etoposide—hematologic cancer	0.00118	0.00264	CbGbCtD
Glyburide—CYP3A4—Triamcinolone—hematologic cancer	0.00117	0.00261	CbGbCtD
Glyburide—CYP3A4—Dasatinib—hematologic cancer	0.00114	0.00254	CbGbCtD
Glyburide—CPT1A—gonad—hematologic cancer	0.00113	0.0309	CbGeAlD
Glyburide—ABCC9—testis—hematologic cancer	0.00112	0.0306	CbGeAlD
Glyburide—CYP3A4—Mitoxantrone—hematologic cancer	0.00112	0.00251	CbGbCtD
Glyburide—CYP2C9—Dexamethasone—hematologic cancer	0.001	0.00224	CbGbCtD
Glyburide—CYP3A4—Betamethasone—hematologic cancer	0.001	0.00224	CbGbCtD
Glyburide—CPT1A—blood—hematologic cancer	0.000988	0.0269	CbGeAlD
Glyburide—CYP3A4—Prednisolone—hematologic cancer	0.000987	0.00221	CbGbCtD
Glyburide—ABCB1—Dexamethasone—hematologic cancer	0.000972	0.00217	CbGbCtD
Glyburide—CYP3A4—Prednisone—hematologic cancer	0.000932	0.00209	CbGbCtD
Glyburide—ABCA1—blood—hematologic cancer	0.00092	0.0251	CbGeAlD
Glyburide—KCNJ11—hematopoietic system—hematologic cancer	0.000886	0.0242	CbGeAlD
Glyburide—CYP3A4—Irinotecan—hematologic cancer	0.000884	0.00198	CbGbCtD
Glyburide—CFTR—blood—hematologic cancer	0.000869	0.0237	CbGeAlD
Glyburide—CPT1A—lung—hematologic cancer	0.000866	0.0236	CbGeAlD
Glyburide—CPT1A—testis—hematologic cancer	0.000817	0.0223	CbGeAlD
Glyburide—ABCC9—lymph node—hematologic cancer	0.000814	0.0222	CbGeAlD
Glyburide—ABCA1—lung—hematologic cancer	0.000807	0.022	CbGeAlD
Glyburide—ABCB1—Doxorubicin—hematologic cancer	0.000806	0.0018	CbGbCtD
Glyburide—CYP3A4—Vinblastine—hematologic cancer	0.000786	0.00176	CbGbCtD
Glyburide—ABCB1—Methotrexate—hematologic cancer	0.000781	0.00175	CbGbCtD
Glyburide—CYP3A4—Vincristine—hematologic cancer	0.000773	0.00173	CbGbCtD
Glyburide—CFTR—lung—hematologic cancer	0.000762	0.0208	CbGeAlD
Glyburide—ABCA1—testis—hematologic cancer	0.000761	0.0208	CbGeAlD
Glyburide—CFTR—testis—hematologic cancer	0.000719	0.0196	CbGeAlD
Glyburide—CYP3A4—Etoposide—hematologic cancer	0.000708	0.00158	CbGbCtD
Glyburide—ABCC3—hematopoietic system—hematologic cancer	0.000685	0.0187	CbGeAlD
Glyburide—SLCO2B1—hematopoietic system—hematologic cancer	0.000639	0.0174	CbGeAlD
Glyburide—CPT1A—lymph node—hematologic cancer	0.000592	0.0162	CbGeAlD
Glyburide—ABCB11—testis—hematologic cancer	0.00059	0.0161	CbGeAlD
Glyburide—SLCO1A2—hematopoietic system—hematologic cancer	0.000588	0.016	CbGeAlD
Glyburide—CYP3A4—Dexamethasone—hematologic cancer	0.000582	0.0013	CbGbCtD
Glyburide—ABCA1—lymph node—hematologic cancer	0.000552	0.015	CbGeAlD
Glyburide—Sulpiride—CA9—hematologic cancer	0.000543	0.378	CrCbGaD
Glyburide—SLC22A7—testis—hematologic cancer	0.000532	0.0145	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—hematologic cancer	0.000483	0.00108	CbGbCtD
Glyburide—CYP2C19—hematopoietic system—hematologic cancer	0.00047	0.0128	CbGeAlD
Glyburide—ABCC3—blood—hematologic cancer	0.000454	0.0124	CbGeAlD
Glyburide—ABCC8—testis—hematologic cancer	0.000447	0.0122	CbGeAlD
Glyburide—Gliclazide—VEGFA—hematologic cancer	0.00041	0.285	CrCbGaD
Glyburide—ABCC3—lung—hematologic cancer	0.000398	0.0108	CbGeAlD
Glyburide—ABCC3—testis—hematologic cancer	0.000375	0.0102	CbGeAlD
Glyburide—SLCO2B1—lung—hematologic cancer	0.000371	0.0101	CbGeAlD
Glyburide—CYP2C9—hematopoietic system—hematologic cancer	0.000365	0.00994	CbGeAlD
Glyburide—ABCC2—blood—hematologic cancer	0.000363	0.00989	CbGeAlD
Glyburide—KCNJ11—lymph node—hematologic cancer	0.000352	0.00959	CbGeAlD
Glyburide—SLCO2B1—testis—hematologic cancer	0.00035	0.00954	CbGeAlD
Glyburide—SLCO1A2—lung—hematologic cancer	0.000341	0.00931	CbGeAlD
Glyburide—SLC15A2—blood—hematologic cancer	0.000323	0.00881	CbGeAlD
Glyburide—SLCO1A2—testis—hematologic cancer	0.000322	0.00878	CbGeAlD
Glyburide—ALB—testis—hematologic cancer	0.00032	0.00873	CbGeAlD
Glyburide—ABCC1—blood—hematologic cancer	0.000319	0.00871	CbGeAlD
Glyburide—CYP2C19—blood—hematologic cancer	0.000312	0.0085	CbGeAlD
Glyburide—ABCC2—testis—hematologic cancer	0.0003	0.00818	CbGeAlD
Glyburide—Zafirlukast—ABCG2—hematologic cancer	0.000293	0.204	CrCbGaD
Glyburide—SLC15A2—lung—hematologic cancer	0.000283	0.00772	CbGeAlD
Glyburide—ABCC1—lung—hematologic cancer	0.00028	0.00764	CbGeAlD
Glyburide—CYP3A4—hematopoietic system—hematologic cancer	0.000278	0.00758	CbGeAlD
Glyburide—ABCC3—lymph node—hematologic cancer	0.000272	0.00742	CbGeAlD
Glyburide—SLC15A2—testis—hematologic cancer	0.000267	0.00729	CbGeAlD
Glyburide—ABCG2—blood—hematologic cancer	0.000264	0.00721	CbGeAlD
Glyburide—ABCC1—testis—hematologic cancer	0.000264	0.00721	CbGeAlD
Glyburide—ABCG2—bone marrow—hematologic cancer	0.000256	0.00698	CbGeAlD
Glyburide—SLCO2B1—lymph node—hematologic cancer	0.000254	0.00692	CbGeAlD
Glyburide—CYP2C9—blood—hematologic cancer	0.000242	0.00659	CbGeAlD
Glyburide—ALB—lymph node—hematologic cancer	0.000232	0.00633	CbGeAlD
Glyburide—ABCG2—lung—hematologic cancer	0.000232	0.00632	CbGeAlD
Glyburide—ABCG2—testis—hematologic cancer	0.000219	0.00596	CbGeAlD
Glyburide—ABCC2—lymph node—hematologic cancer	0.000217	0.00593	CbGeAlD
Glyburide—ABCB1—hematopoietic system—hematologic cancer	0.000197	0.00537	CbGeAlD
Glyburide—SLC15A2—lymph node—hematologic cancer	0.000194	0.00528	CbGeAlD
Glyburide—ABCC1—lymph node—hematologic cancer	0.000192	0.00522	CbGeAlD
Glyburide—CYP3A4—blood—hematologic cancer	0.000184	0.00502	CbGeAlD
Glyburide—ABCG2—lymph node—hematologic cancer	0.000159	0.00432	CbGeAlD
Glyburide—ABCB1—gonad—hematologic cancer	0.00015	0.00408	CbGeAlD
Glyburide—ABCB1—blood—hematologic cancer	0.00013	0.00356	CbGeAlD
Glyburide—ABCB1—bone marrow—hematologic cancer	0.000126	0.00344	CbGeAlD
Glyburide—ABCB1—lung—hematologic cancer	0.000114	0.00312	CbGeAlD
Glyburide—Gliclazide—ALB—hematologic cancer	0.00011	0.0766	CrCbGaD
Glyburide—ABCB1—testis—hematologic cancer	0.000108	0.00294	CbGeAlD
Glyburide—Chlorpropamide—ABCB1—hematologic cancer	8.17e-05	0.0568	CrCbGaD
Glyburide—ABCB1—lymph node—hematologic cancer	7.82e-05	0.00213	CbGeAlD
Glyburide—Nervous system disorder—Betamethasone—hematologic cancer	2.52e-05	0.000177	CcSEcCtD
Glyburide—Nervous system disorder—Dexamethasone—hematologic cancer	2.52e-05	0.000177	CcSEcCtD
Glyburide—Dermatitis—Alitretinoin—hematologic cancer	2.52e-05	0.000177	CcSEcCtD
Glyburide—Thrombocytopenia—Betamethasone—hematologic cancer	2.52e-05	0.000177	CcSEcCtD
Glyburide—Thrombocytopenia—Dexamethasone—hematologic cancer	2.52e-05	0.000177	CcSEcCtD
Glyburide—Vomiting—Ifosfamide—hematologic cancer	2.51e-05	0.000177	CcSEcCtD
Glyburide—Hypersensitivity—Cisplatin—hematologic cancer	2.51e-05	0.000176	CcSEcCtD
Glyburide—Headache—Alitretinoin—hematologic cancer	2.51e-05	0.000176	CcSEcCtD
Glyburide—Angioedema—Prednisone—hematologic cancer	2.51e-05	0.000176	CcSEcCtD
Glyburide—Diarrhoea—Gemcitabine—hematologic cancer	2.5e-05	0.000176	CcSEcCtD
Glyburide—Nausea—Thalidomide—hematologic cancer	2.5e-05	0.000175	CcSEcCtD
Glyburide—Dyspepsia—Triamcinolone—hematologic cancer	2.49e-05	0.000175	CcSEcCtD
Glyburide—Rash—Ifosfamide—hematologic cancer	2.49e-05	0.000175	CcSEcCtD
Glyburide—Dermatitis—Ifosfamide—hematologic cancer	2.49e-05	0.000175	CcSEcCtD
Glyburide—Hyperhidrosis—Betamethasone—hematologic cancer	2.48e-05	0.000175	CcSEcCtD
Glyburide—Hyperhidrosis—Dexamethasone—hematologic cancer	2.48e-05	0.000175	CcSEcCtD
Glyburide—Urticaria—Etoposide—hematologic cancer	2.48e-05	0.000174	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—hematologic cancer	2.47e-05	0.000174	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—hematologic cancer	2.47e-05	0.000173	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—hematologic cancer	2.46e-05	0.000173	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—hematologic cancer	2.46e-05	0.000173	CcSEcCtD
Glyburide—Vomiting—Vincristine—hematologic cancer	2.45e-05	0.000172	CcSEcCtD
Glyburide—Anorexia—Betamethasone—hematologic cancer	2.45e-05	0.000172	CcSEcCtD
Glyburide—Anorexia—Dexamethasone—hematologic cancer	2.45e-05	0.000172	CcSEcCtD
Glyburide—Urticaria—Prednisolone—hematologic cancer	2.45e-05	0.000172	CcSEcCtD
Glyburide—Asthenia—Cisplatin—hematologic cancer	2.45e-05	0.000172	CcSEcCtD
Glyburide—Rash—Vincristine—hematologic cancer	2.43e-05	0.000171	CcSEcCtD
Glyburide—Dermatitis—Vincristine—hematologic cancer	2.43e-05	0.000171	CcSEcCtD
Glyburide—Headache—Vincristine—hematologic cancer	2.41e-05	0.00017	CcSEcCtD
Glyburide—Hypotension—Dexamethasone—hematologic cancer	2.4e-05	0.000169	CcSEcCtD
Glyburide—Hypotension—Betamethasone—hematologic cancer	2.4e-05	0.000169	CcSEcCtD
Glyburide—Nausea—Carmustine—hematologic cancer	2.4e-05	0.000168	CcSEcCtD
Glyburide—Vomiting—Irinotecan—hematologic cancer	2.39e-05	0.000168	CcSEcCtD
Glyburide—Vomiting—Mitoxantrone—hematologic cancer	2.39e-05	0.000168	CcSEcCtD
Glyburide—Nausea—Alitretinoin—hematologic cancer	2.38e-05	0.000167	CcSEcCtD
Glyburide—Convulsion—Prednisone—hematologic cancer	2.38e-05	0.000167	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—hematologic cancer	2.37e-05	0.000167	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—hematologic cancer	2.37e-05	0.000166	CcSEcCtD
Glyburide—Rash—Irinotecan—hematologic cancer	2.37e-05	0.000166	CcSEcCtD
Glyburide—Rash—Mitoxantrone—hematologic cancer	2.37e-05	0.000166	CcSEcCtD
Glyburide—Dermatitis—Mitoxantrone—hematologic cancer	2.36e-05	0.000166	CcSEcCtD
Glyburide—Dermatitis—Irinotecan—hematologic cancer	2.36e-05	0.000166	CcSEcCtD
Glyburide—Headache—Mitoxantrone—hematologic cancer	2.35e-05	0.000165	CcSEcCtD
Glyburide—Headache—Irinotecan—hematologic cancer	2.35e-05	0.000165	CcSEcCtD
Glyburide—Nausea—Ifosfamide—hematologic cancer	2.35e-05	0.000165	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.34e-05	0.000164	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.34e-05	0.000164	CcSEcCtD
Glyburide—Myalgia—Prednisone—hematologic cancer	2.33e-05	0.000164	CcSEcCtD
Glyburide—Arthralgia—Prednisone—hematologic cancer	2.33e-05	0.000164	CcSEcCtD
Glyburide—Feeling abnormal—Triamcinolone—hematologic cancer	2.33e-05	0.000164	CcSEcCtD
Glyburide—Diarrhoea—Cisplatin—hematologic cancer	2.33e-05	0.000164	CcSEcCtD
Glyburide—Alopecia—Methotrexate—hematologic cancer	2.33e-05	0.000163	CcSEcCtD
Glyburide—Vomiting—Gemcitabine—hematologic cancer	2.32e-05	0.000163	CcSEcCtD
Glyburide—Paraesthesia—Dexamethasone—hematologic cancer	2.31e-05	0.000162	CcSEcCtD
Glyburide—Paraesthesia—Betamethasone—hematologic cancer	2.31e-05	0.000162	CcSEcCtD
Glyburide—Rash—Gemcitabine—hematologic cancer	2.31e-05	0.000162	CcSEcCtD
Glyburide—Dermatitis—Gemcitabine—hematologic cancer	2.3e-05	0.000162	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—hematologic cancer	2.3e-05	0.000162	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—hematologic cancer	2.3e-05	0.000162	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—hematologic cancer	2.29e-05	0.000161	CcSEcCtD
Glyburide—Erythema—Methotrexate—hematologic cancer	2.29e-05	0.000161	CcSEcCtD
Glyburide—Headache—Gemcitabine—hematologic cancer	2.29e-05	0.000161	CcSEcCtD
Glyburide—Nausea—Vincristine—hematologic cancer	2.29e-05	0.000161	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—hematologic cancer	2.28e-05	0.00016	CcSEcCtD
Glyburide—Hypersensitivity—Prednisolone—hematologic cancer	2.27e-05	0.000159	CcSEcCtD
Glyburide—Dyspepsia—Betamethasone—hematologic cancer	2.26e-05	0.000159	CcSEcCtD
Glyburide—Dyspepsia—Dexamethasone—hematologic cancer	2.26e-05	0.000159	CcSEcCtD
Glyburide—Urticaria—Triamcinolone—hematologic cancer	2.25e-05	0.000158	CcSEcCtD
Glyburide—Asthenia—Etoposide—hematologic cancer	2.24e-05	0.000157	CcSEcCtD
Glyburide—Oedema—Prednisone—hematologic cancer	2.24e-05	0.000157	CcSEcCtD
Glyburide—Decreased appetite—Betamethasone—hematologic cancer	2.23e-05	0.000157	CcSEcCtD
Glyburide—Decreased appetite—Dexamethasone—hematologic cancer	2.23e-05	0.000157	CcSEcCtD
Glyburide—Nausea—Mitoxantrone—hematologic cancer	2.23e-05	0.000157	CcSEcCtD
Glyburide—Nausea—Irinotecan—hematologic cancer	2.23e-05	0.000157	CcSEcCtD
Glyburide—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.22e-05	0.000156	CcSEcCtD
Glyburide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.22e-05	0.000156	CcSEcCtD
Glyburide—Pruritus—Etoposide—hematologic cancer	2.21e-05	0.000155	CcSEcCtD
Glyburide—Shock—Prednisone—hematologic cancer	2.2e-05	0.000155	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—hematologic cancer	2.2e-05	0.000154	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—hematologic cancer	2.19e-05	0.000154	CcSEcCtD
Glyburide—Alopecia—Epirubicin—hematologic cancer	2.18e-05	0.000153	CcSEcCtD
Glyburide—Nausea—Gemcitabine—hematologic cancer	2.17e-05	0.000153	CcSEcCtD
Glyburide—Vomiting—Cisplatin—hematologic cancer	2.17e-05	0.000152	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—hematologic cancer	2.16e-05	0.000152	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—hematologic cancer	2.16e-05	0.000152	CcSEcCtD
Glyburide—Rash—Cisplatin—hematologic cancer	2.15e-05	0.000151	CcSEcCtD
Glyburide—Dermatitis—Cisplatin—hematologic cancer	2.15e-05	0.000151	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—hematologic cancer	2.14e-05	0.000151	CcSEcCtD
Glyburide—Erythema—Epirubicin—hematologic cancer	2.14e-05	0.000151	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—hematologic cancer	2.14e-05	0.00015	CcSEcCtD
Glyburide—Anorexia—Prednisone—hematologic cancer	2.13e-05	0.00015	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—hematologic cancer	2.13e-05	0.00015	CcSEcCtD
Glyburide—Anaemia—Methotrexate—hematologic cancer	2.12e-05	0.000149	CcSEcCtD
Glyburide—Feeling abnormal—Betamethasone—hematologic cancer	2.12e-05	0.000149	CcSEcCtD
Glyburide—Feeling abnormal—Dexamethasone—hematologic cancer	2.12e-05	0.000149	CcSEcCtD
Glyburide—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.1e-05	0.000148	CcSEcCtD
Glyburide—Gastrointestinal pain—Betamethasone—hematologic cancer	2.1e-05	0.000148	CcSEcCtD
Glyburide—Hypersensitivity—Triamcinolone—hematologic cancer	2.09e-05	0.000147	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—hematologic cancer	2.05e-05	0.000144	CcSEcCtD
Glyburide—Urticaria—Betamethasone—hematologic cancer	2.04e-05	0.000143	CcSEcCtD
Glyburide—Urticaria—Dexamethasone—hematologic cancer	2.04e-05	0.000143	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.04e-05	0.000143	CcSEcCtD
Glyburide—Asthenia—Triamcinolone—hematologic cancer	2.03e-05	0.000143	CcSEcCtD
Glyburide—Abdominal pain—Betamethasone—hematologic cancer	2.03e-05	0.000143	CcSEcCtD
Glyburide—Abdominal pain—Dexamethasone—hematologic cancer	2.03e-05	0.000143	CcSEcCtD
Glyburide—Nausea—Cisplatin—hematologic cancer	2.02e-05	0.000142	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—hematologic cancer	2.02e-05	0.000142	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—hematologic cancer	2.01e-05	0.000142	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—hematologic cancer	2.01e-05	0.000141	CcSEcCtD
Glyburide—Pruritus—Triamcinolone—hematologic cancer	2e-05	0.000141	CcSEcCtD
Glyburide—Convulsion—Methotrexate—hematologic cancer	1.99e-05	0.000139	CcSEcCtD
Glyburide—Vomiting—Etoposide—hematologic cancer	1.99e-05	0.000139	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—hematologic cancer	1.98e-05	0.000139	CcSEcCtD
Glyburide—Erythema—Doxorubicin—hematologic cancer	1.98e-05	0.000139	CcSEcCtD
Glyburide—Anaemia—Epirubicin—hematologic cancer	1.98e-05	0.000139	CcSEcCtD
Glyburide—Dyspepsia—Prednisone—hematologic cancer	1.97e-05	0.000138	CcSEcCtD
Glyburide—Rash—Etoposide—hematologic cancer	1.97e-05	0.000138	CcSEcCtD
Glyburide—Dermatitis—Etoposide—hematologic cancer	1.97e-05	0.000138	CcSEcCtD
Glyburide—Headache—Etoposide—hematologic cancer	1.96e-05	0.000137	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—hematologic cancer	1.95e-05	0.000137	CcSEcCtD
Glyburide—Myalgia—Methotrexate—hematologic cancer	1.95e-05	0.000137	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—hematologic cancer	1.95e-05	0.000137	CcSEcCtD
Glyburide—Rash—Prednisolone—hematologic cancer	1.94e-05	0.000136	CcSEcCtD
Glyburide—Dermatitis—Prednisolone—hematologic cancer	1.94e-05	0.000136	CcSEcCtD
Glyburide—Headache—Prednisolone—hematologic cancer	1.93e-05	0.000136	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—hematologic cancer	1.92e-05	0.000135	CcSEcCtD
Glyburide—Confusional state—Methotrexate—hematologic cancer	1.89e-05	0.000132	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—hematologic cancer	1.87e-05	0.000131	CcSEcCtD
Glyburide—Convulsion—Epirubicin—hematologic cancer	1.86e-05	0.000131	CcSEcCtD
Glyburide—Nausea—Etoposide—hematologic cancer	1.85e-05	0.00013	CcSEcCtD
Glyburide—Feeling abnormal—Prednisone—hematologic cancer	1.84e-05	0.00013	CcSEcCtD
Glyburide—Asthenia—Dexamethasone—hematologic cancer	1.84e-05	0.00013	CcSEcCtD
Glyburide—Asthenia—Betamethasone—hematologic cancer	1.84e-05	0.00013	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—hematologic cancer	1.83e-05	0.000129	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—hematologic cancer	1.83e-05	0.000129	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—hematologic cancer	1.83e-05	0.000129	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—hematologic cancer	1.83e-05	0.000129	CcSEcCtD
Glyburide—Nausea—Prednisolone—hematologic cancer	1.83e-05	0.000129	CcSEcCtD
Glyburide—Myalgia—Epirubicin—hematologic cancer	1.83e-05	0.000128	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—hematologic cancer	1.83e-05	0.000128	CcSEcCtD
Glyburide—Pruritus—Dexamethasone—hematologic cancer	1.82e-05	0.000128	CcSEcCtD
Glyburide—Pruritus—Betamethasone—hematologic cancer	1.82e-05	0.000128	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—hematologic cancer	1.81e-05	0.000127	CcSEcCtD
Glyburide—Vomiting—Triamcinolone—hematologic cancer	1.8e-05	0.000127	CcSEcCtD
Glyburide—Rash—Triamcinolone—hematologic cancer	1.79e-05	0.000125	CcSEcCtD
Glyburide—Dermatitis—Triamcinolone—hematologic cancer	1.78e-05	0.000125	CcSEcCtD
Glyburide—Anorexia—Methotrexate—hematologic cancer	1.78e-05	0.000125	CcSEcCtD
Glyburide—Urticaria—Prednisone—hematologic cancer	1.78e-05	0.000125	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—hematologic cancer	1.78e-05	0.000125	CcSEcCtD
Glyburide—Headache—Triamcinolone—hematologic cancer	1.77e-05	0.000125	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—hematologic cancer	1.77e-05	0.000124	CcSEcCtD
Glyburide—Confusional state—Epirubicin—hematologic cancer	1.76e-05	0.000124	CcSEcCtD
Glyburide—Diarrhoea—Dexamethasone—hematologic cancer	1.76e-05	0.000124	CcSEcCtD
Glyburide—Diarrhoea—Betamethasone—hematologic cancer	1.76e-05	0.000124	CcSEcCtD
Glyburide—Oedema—Epirubicin—hematologic cancer	1.75e-05	0.000123	CcSEcCtD
Glyburide—Hypotension—Methotrexate—hematologic cancer	1.75e-05	0.000123	CcSEcCtD
Glyburide—Shock—Epirubicin—hematologic cancer	1.72e-05	0.000121	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—hematologic cancer	1.72e-05	0.000121	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—hematologic cancer	1.72e-05	0.000121	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—hematologic cancer	1.71e-05	0.00012	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.7e-05	0.00012	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—hematologic cancer	1.69e-05	0.000119	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—hematologic cancer	1.69e-05	0.000119	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—hematologic cancer	1.69e-05	0.000119	CcSEcCtD
Glyburide—Nausea—Triamcinolone—hematologic cancer	1.68e-05	0.000118	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—hematologic cancer	1.68e-05	0.000118	CcSEcCtD
Glyburide—Anorexia—Epirubicin—hematologic cancer	1.67e-05	0.000117	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—hematologic cancer	1.67e-05	0.000117	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—hematologic cancer	1.65e-05	0.000116	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—hematologic cancer	1.65e-05	0.000116	CcSEcCtD
Glyburide—Hypotension—Epirubicin—hematologic cancer	1.64e-05	0.000115	CcSEcCtD
Glyburide—Vomiting—Betamethasone—hematologic cancer	1.63e-05	0.000115	CcSEcCtD
Glyburide—Vomiting—Dexamethasone—hematologic cancer	1.63e-05	0.000115	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—hematologic cancer	1.63e-05	0.000115	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—hematologic cancer	1.63e-05	0.000114	CcSEcCtD
Glyburide—Rash—Dexamethasone—hematologic cancer	1.62e-05	0.000114	CcSEcCtD
Glyburide—Rash—Betamethasone—hematologic cancer	1.62e-05	0.000114	CcSEcCtD
Glyburide—Oedema—Doxorubicin—hematologic cancer	1.62e-05	0.000114	CcSEcCtD
Glyburide—Dermatitis—Dexamethasone—hematologic cancer	1.62e-05	0.000114	CcSEcCtD
Glyburide—Dermatitis—Betamethasone—hematologic cancer	1.62e-05	0.000114	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.61e-05	0.000113	CcSEcCtD
Glyburide—Headache—Dexamethasone—hematologic cancer	1.61e-05	0.000113	CcSEcCtD
Glyburide—Headache—Betamethasone—hematologic cancer	1.61e-05	0.000113	CcSEcCtD
Glyburide—Asthenia—Prednisone—hematologic cancer	1.61e-05	0.000113	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.59e-05	0.000112	CcSEcCtD
Glyburide—Shock—Doxorubicin—hematologic cancer	1.59e-05	0.000112	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—hematologic cancer	1.59e-05	0.000112	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—hematologic cancer	1.59e-05	0.000111	CcSEcCtD
Glyburide—Pruritus—Prednisone—hematologic cancer	1.58e-05	0.000111	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—hematologic cancer	1.57e-05	0.00011	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—hematologic cancer	1.57e-05	0.00011	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—hematologic cancer	1.56e-05	0.00011	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—hematologic cancer	1.54e-05	0.000108	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—hematologic cancer	1.54e-05	0.000108	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—hematologic cancer	1.54e-05	0.000108	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—hematologic cancer	1.53e-05	0.000108	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—hematologic cancer	1.53e-05	0.000107	CcSEcCtD
Glyburide—Nausea—Betamethasone—hematologic cancer	1.53e-05	0.000107	CcSEcCtD
Glyburide—Nausea—Dexamethasone—hematologic cancer	1.53e-05	0.000107	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—hematologic cancer	1.52e-05	0.000107	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—hematologic cancer	1.51e-05	0.000106	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.51e-05	0.000106	CcSEcCtD
Glyburide—Urticaria—Methotrexate—hematologic cancer	1.49e-05	0.000104	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—hematologic cancer	1.48e-05	0.000104	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.48e-05	0.000104	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—hematologic cancer	1.45e-05	0.000102	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—hematologic cancer	1.44e-05	0.000101	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—hematologic cancer	1.44e-05	0.000101	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—hematologic cancer	1.43e-05	0.000101	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—hematologic cancer	1.43e-05	0.0001	CcSEcCtD
Glyburide—Vomiting—Prednisone—hematologic cancer	1.42e-05	0.0001	CcSEcCtD
Glyburide—Rash—Prednisone—hematologic cancer	1.41e-05	9.91e-05	CcSEcCtD
Glyburide—Dermatitis—Prednisone—hematologic cancer	1.41e-05	9.9e-05	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—hematologic cancer	1.41e-05	9.89e-05	CcSEcCtD
Glyburide—Headache—Prednisone—hematologic cancer	1.4e-05	9.85e-05	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.4e-05	9.82e-05	CcSEcCtD
Glyburide—Urticaria—Epirubicin—hematologic cancer	1.39e-05	9.77e-05	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—hematologic cancer	1.38e-05	9.72e-05	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—hematologic cancer	1.38e-05	9.68e-05	CcSEcCtD
Glyburide—Asthenia—Methotrexate—hematologic cancer	1.34e-05	9.43e-05	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—hematologic cancer	1.33e-05	9.38e-05	CcSEcCtD
Glyburide—Nausea—Prednisone—hematologic cancer	1.33e-05	9.34e-05	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.32e-05	9.3e-05	CcSEcCtD
Glyburide—Pruritus—Methotrexate—hematologic cancer	1.32e-05	9.3e-05	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—hematologic cancer	1.29e-05	9.06e-05	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—hematologic cancer	1.29e-05	9.04e-05	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—hematologic cancer	1.28e-05	8.99e-05	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—hematologic cancer	1.28e-05	8.99e-05	CcSEcCtD
Glyburide—Asthenia—Epirubicin—hematologic cancer	1.26e-05	8.82e-05	CcSEcCtD
Glyburide—Pruritus—Epirubicin—hematologic cancer	1.24e-05	8.7e-05	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—hematologic cancer	1.2e-05	8.41e-05	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—hematologic cancer	1.19e-05	8.38e-05	CcSEcCtD
Glyburide—Vomiting—Methotrexate—hematologic cancer	1.19e-05	8.35e-05	CcSEcCtD
Glyburide—Rash—Methotrexate—hematologic cancer	1.18e-05	8.28e-05	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—hematologic cancer	1.18e-05	8.28e-05	CcSEcCtD
Glyburide—Headache—Methotrexate—hematologic cancer	1.17e-05	8.23e-05	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—hematologic cancer	1.16e-05	8.16e-05	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—hematologic cancer	1.15e-05	8.05e-05	CcSEcCtD
Glyburide—Vomiting—Epirubicin—hematologic cancer	1.11e-05	7.82e-05	CcSEcCtD
Glyburide—Nausea—Methotrexate—hematologic cancer	1.11e-05	7.8e-05	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—hematologic cancer	1.11e-05	7.78e-05	CcSEcCtD
Glyburide—Rash—Epirubicin—hematologic cancer	1.1e-05	7.75e-05	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—hematologic cancer	1.1e-05	7.75e-05	CcSEcCtD
Glyburide—Headache—Epirubicin—hematologic cancer	1.1e-05	7.7e-05	CcSEcCtD
Glyburide—Nausea—Epirubicin—hematologic cancer	1.04e-05	7.3e-05	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—hematologic cancer	1.03e-05	7.23e-05	CcSEcCtD
Glyburide—Rash—Doxorubicin—hematologic cancer	1.02e-05	7.17e-05	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—hematologic cancer	1.02e-05	7.17e-05	CcSEcCtD
Glyburide—Headache—Doxorubicin—hematologic cancer	1.01e-05	7.13e-05	CcSEcCtD
Glyburide—Nausea—Doxorubicin—hematologic cancer	9.62e-06	6.76e-05	CcSEcCtD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.2e-06	2.88e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—EP300—hematologic cancer	2.18e-06	2.86e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ENO2—hematologic cancer	2.18e-06	2.85e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3R1—hematologic cancer	2.17e-06	2.85e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTR—hematologic cancer	2.17e-06	2.84e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ABCG2—hematologic cancer	2.17e-06	2.84e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAP2K1—hematologic cancer	2.17e-06	2.84e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CD—hematologic cancer	2.16e-06	2.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.15e-06	2.82e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—MTHFR—hematologic cancer	2.15e-06	2.81e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NUP98—hematologic cancer	2.15e-06	2.81e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—hematologic cancer	2.14e-06	2.79e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—hematologic cancer	2.14e-06	2.79e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ENO2—hematologic cancer	2.13e-06	2.79e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—EP300—hematologic cancer	2.12e-06	2.77e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTT1—hematologic cancer	2.12e-06	2.77e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CREBBP—hematologic cancer	2.12e-06	2.77e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CB—hematologic cancer	2.11e-06	2.76e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CB—hematologic cancer	2.09e-06	2.74e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ADCY7—hematologic cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOA3—hematologic cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.08e-06	2.72e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—FHL2—hematologic cancer	2.08e-06	2.72e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NUP214—hematologic cancer	2.07e-06	2.71e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SDC1—hematologic cancer	2.07e-06	2.71e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTT1—hematologic cancer	2.07e-06	2.7e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGF2—hematologic cancer	2.06e-06	2.7e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—hematologic cancer	2.05e-06	2.69e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.05e-06	2.68e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AGRN—hematologic cancer	2.04e-06	2.66e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	2.04e-06	2.66e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3R1—hematologic cancer	2.03e-06	2.66e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCG2—hematologic cancer	2.03e-06	2.65e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTR—hematologic cancer	2.03e-06	2.65e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SDC1—hematologic cancer	2.02e-06	2.64e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—hematologic cancer	2.01e-06	2.63e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	2.01e-06	2.62e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2e-06	2.62e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ENO2—hematologic cancer	1.99e-06	2.6e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—hematologic cancer	1.98e-06	2.59e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—JAK2—hematologic cancer	1.98e-06	2.59e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.98e-06	2.59e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CD44—hematologic cancer	1.96e-06	2.56e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NQO1—hematologic cancer	1.96e-06	2.56e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.95e-06	2.55e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—hematologic cancer	1.93e-06	2.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.93e-06	2.53e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MDM2—hematologic cancer	1.93e-06	2.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—IDH2—hematologic cancer	1.93e-06	2.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMMR—hematologic cancer	1.93e-06	2.53e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.93e-06	2.52e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.92e-06	2.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CREBBP—hematologic cancer	1.9e-06	2.49e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.9e-06	2.49e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SDC1—hematologic cancer	1.89e-06	2.47e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTOR—hematologic cancer	1.88e-06	2.46e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—hematologic cancer	1.88e-06	2.46e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—hematologic cancer	1.87e-06	2.45e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.87e-06	2.44e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYCS—hematologic cancer	1.85e-06	2.43e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HSP90AA1—hematologic cancer	1.84e-06	2.41e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.81e-06	2.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.81e-06	2.37e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—hematologic cancer	1.81e-06	2.37e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—hematologic cancer	1.81e-06	2.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—hematologic cancer	1.8e-06	2.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.8e-06	2.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—hematologic cancer	1.78e-06	2.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.78e-06	2.33e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ACP5—hematologic cancer	1.76e-06	2.31e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CA9—hematologic cancer	1.76e-06	2.31e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—hematologic cancer	1.76e-06	2.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NQO1—hematologic cancer	1.76e-06	2.3e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CD44—hematologic cancer	1.76e-06	2.3e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	1.75e-06	2.29e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.74e-06	2.28e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EP300—hematologic cancer	1.74e-06	2.27e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—hematologic cancer	1.73e-06	2.27e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—EP300—hematologic cancer	1.73e-06	2.26e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CD44—hematologic cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NQO1—hematologic cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3R1—hematologic cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—hematologic cancer	1.69e-06	2.21e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CREBBP—hematologic cancer	1.67e-06	2.19e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYCS—hematologic cancer	1.66e-06	2.18e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—IDH1—hematologic cancer	1.66e-06	2.17e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.66e-06	2.17e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—EP300—hematologic cancer	1.65e-06	2.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.65e-06	2.16e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—hematologic cancer	1.64e-06	2.15e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TXN—hematologic cancer	1.64e-06	2.15e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.64e-06	2.15e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.64e-06	2.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—hematologic cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—hematologic cancer	1.63e-06	2.13e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—hematologic cancer	1.62e-06	2.13e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYCS—hematologic cancer	1.62e-06	2.13e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—hematologic cancer	1.62e-06	2.12e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—hematologic cancer	1.61e-06	2.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.61e-06	2.11e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.61e-06	2.1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NQO1—hematologic cancer	1.6e-06	2.1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CD44—hematologic cancer	1.6e-06	2.1e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—hematologic cancer	1.59e-06	2.08e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.58e-06	2.07e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—hematologic cancer	1.57e-06	2.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.57e-06	2.05e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—hematologic cancer	1.57e-06	2.05e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—hematologic cancer	1.57e-06	2.05e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—hematologic cancer	1.56e-06	2.04e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EP300—hematologic cancer	1.55e-06	2.03e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCB1—hematologic cancer	1.55e-06	2.02e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.54e-06	2.02e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYCS—hematologic cancer	1.52e-06	1.99e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—hematologic cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.51e-06	1.97e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—hematologic cancer	1.51e-06	1.97e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NCOR1—hematologic cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—hematologic cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.49e-06	1.95e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.47e-06	1.92e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.46e-06	1.91e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—hematologic cancer	1.45e-06	1.9e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—hematologic cancer	1.45e-06	1.9e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—EP300—hematologic cancer	1.44e-06	1.89e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—hematologic cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.42e-06	1.86e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NUP98—hematologic cancer	1.42e-06	1.85e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—hematologic cancer	1.4e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.39e-06	1.82e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—hematologic cancer	1.39e-06	1.82e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.38e-06	1.8e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.38e-06	1.8e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NUP214—hematologic cancer	1.37e-06	1.79e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—hematologic cancer	1.36e-06	1.78e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.36e-06	1.78e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—hematologic cancer	1.35e-06	1.77e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.35e-06	1.76e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.35e-06	1.76e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—hematologic cancer	1.35e-06	1.76e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTR—hematologic cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—hematologic cancer	1.33e-06	1.74e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—hematologic cancer	1.32e-06	1.73e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—hematologic cancer	1.32e-06	1.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NCOR1—hematologic cancer	1.32e-06	1.72e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ENO2—hematologic cancer	1.31e-06	1.72e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—EP300—hematologic cancer	1.3e-06	1.7e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—hematologic cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—hematologic cancer	1.28e-06	1.67e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—hematologic cancer	1.28e-06	1.67e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.27e-06	1.67e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.27e-06	1.66e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—hematologic cancer	1.25e-06	1.63e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SDC1—hematologic cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—hematologic cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.23e-06	1.61e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—hematologic cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—hematologic cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—hematologic cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.17e-06	1.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—hematologic cancer	1.16e-06	1.52e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—hematologic cancer	1.15e-06	1.5e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—EP300—hematologic cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—hematologic cancer	1.11e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.09e-06	1.42e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.07e-06	1.39e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—hematologic cancer	1.06e-06	1.39e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CD44—hematologic cancer	1.06e-06	1.38e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NQO1—hematologic cancer	1.06e-06	1.38e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—hematologic cancer	1.04e-06	1.36e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CREBBP—hematologic cancer	1.03e-06	1.35e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—hematologic cancer	1.01e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1e-06	1.31e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYCS—hematologic cancer	1e-06	1.31e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—hematologic cancer	1e-06	1.31e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	9.94e-07	1.3e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—hematologic cancer	9.8e-07	1.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—hematologic cancer	9.77e-07	1.28e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—hematologic cancer	9.59e-07	1.26e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.57e-07	1.25e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—hematologic cancer	9.35e-07	1.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CREBBP—hematologic cancer	9.28e-07	1.21e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3R1—hematologic cancer	9.25e-07	1.21e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	9.12e-07	1.19e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CREBBP—hematologic cancer	9.06e-07	1.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—hematologic cancer	8.82e-07	1.15e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—hematologic cancer	8.8e-07	1.15e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—hematologic cancer	8.71e-07	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—hematologic cancer	8.68e-07	1.14e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—hematologic cancer	8.59e-07	1.12e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—hematologic cancer	8.54e-07	1.12e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—hematologic cancer	8.48e-07	1.11e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CREBBP—hematologic cancer	8.46e-07	1.11e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—hematologic cancer	8.44e-07	1.1e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCB1—hematologic cancer	8.35e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3R1—hematologic cancer	8.31e-07	1.09e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3R1—hematologic cancer	8.11e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.1e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.1e-07	1.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	8.02e-07	1.05e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—hematologic cancer	7.92e-07	1.04e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—hematologic cancer	7.83e-07	1.03e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—hematologic cancer	7.67e-07	1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	7.57e-07	9.91e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—hematologic cancer	7.48e-07	9.79e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—hematologic cancer	7.38e-07	9.66e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.16e-07	9.37e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—EP300—hematologic cancer	7.04e-07	9.21e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	6.99e-07	9.15e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—hematologic cancer	6.89e-07	9.02e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—hematologic cancer	6.63e-07	8.67e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—hematologic cancer	6.47e-07	8.46e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—EP300—hematologic cancer	6.32e-07	8.27e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—EP300—hematologic cancer	6.17e-07	8.07e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—hematologic cancer	6.04e-07	7.91e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.02e-07	7.88e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—EP300—hematologic cancer	5.76e-07	7.54e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.58e-07	7.3e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.29e-07	6.92e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—hematologic cancer	5.22e-07	6.83e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—hematologic cancer	5.21e-07	6.81e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5e-07	6.54e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—hematologic cancer	4.67e-07	6.12e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.61e-07	6.03e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—hematologic cancer	4.56e-07	5.97e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	4.26e-07	5.58e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—hematologic cancer	4.25e-07	5.57e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—hematologic cancer	3.98e-07	5.21e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—hematologic cancer	3.82e-07	5e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—EP300—hematologic cancer	3.8e-07	4.97e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—hematologic cancer	3.73e-07	4.88e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—hematologic cancer	3.48e-07	4.56e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.81e-07	3.68e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—hematologic cancer	2.3e-07	3.01e-06	CbGpPWpGaD
